Sarepta Therapeutics
Trade Sarepta Therapeutics 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About SRPT
Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.
SRPT Key Statistics
Stock Snapshot
Sarepta Therapeutics(SRPT) stock is priced at $21.30, giving the company a market capitalization of 2.24B. It carries a P/E multiple of -7.66.
On 2026-01-28, Sarepta Therapeutics(SRPT) stock traded between a low of $21.22 and a high of $22.34. Shares are currently priced at $21.30, which is +0.4% above the low and -4.7% below the high.
Sarepta Therapeutics(SRPT) shares are trading with a volume of 2.31M, against a daily average of 3.14M.
In the last year, Sarepta Therapeutics(SRPT) shares hit a 52-week high of $120.05 and a 52-week low of $10.42.
In the last year, Sarepta Therapeutics(SRPT) shares hit a 52-week high of $120.05 and a 52-week low of $10.42.
SRPT News
Barclays assumed coverage of Sarepta (SRPT) with an Equal Weight rating and $20 price target Barclays initiated coverage of 12 biotech stocks and assumed covera...
Baird raised the firm’s price target on Sarepta (SRPT) to $22 from $15 and keeps a Neutral rating on the shares. The firm updated its model following the releas...
Citi analyst Yigal Nochomovitz has assigned their bearish stance on SRPT stock, giving a Sell rating today. Claim 50% Off TipRanks Premium Unlock hedge fund-lev...
Analyst ratings
54%
of 26 ratingsMore SRPT News
Sarepta Therapeutics (NasdaqGS:SRPT) reported positive 3 year data from the EMBARK Phase 3 study of Elevidys gene therapy in Duchenne muscular dystrophy. The r...
U.S. stocks were higher, with the Dow Jones gaining over 100 points on Monday. Shares of Sarepta Therapeutics Inc (NASDAQ:SRPT) rose sharply during Monday's se...
Sarepta Therapeutics Inc. (NASDAQ:SRPT) on Monday released topline three-year functional results from Part 1-treated patients in the EMBARK (Study SRP-9001-301)...
Sarepta (SRPT) Therapeutics announced “positive” topline three-year functional results from Part 1-treated patients in EMBARK, the global, randomized placebo-co...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.